Table 1 Structure of the selected ligands.

From: Establishing FDA-approved oncology drugs as GPR176 inhibitor through homology modelling, molecular docking, MMGBSA, DFT, and molecular dynamics simulation

Name of the compounds used as ligands

2D structures

Fostamatinib

View full size image

Ticagrelor

View full size image

Vismodegib (control)

View full size image

Back to article page